Chinese Journal of Tissue Engineering Research ›› 2025, Vol. 29 ›› Issue (6): 1183-1191.doi: 10.12307/2025.269

Previous Articles     Next Articles

Hemin regulates mitochondrial pathway of oxidative stress in mouse chondrocytes

He Guanghui1, Yuan Jie1, Ke Yanqin1, Qiu Xiaoting1, Zhang Xiaoling1, 2   

  1. 1Department of Orthopedics, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China; 2Department of Orthopedics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200092, China
  • Received:2024-01-25 Accepted:2024-03-07 Online:2025-02-28 Published:2024-06-21
  • Contact: Zhang Xiaoling, MD, Professor, Department of Orthopedics, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China; Department of Orthopedics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200092, China
  • About author:He Guanghui, Master candidate, Department of Orthopedics, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
  • Supported by:
    Key Research and Development Project of Shanxi Province, No. 201903D321097 (to ZXL)

Abstract:
BACKGROUND:
Studies have shown that mitochondrial oxidative stress has an important role in the development of knee osteoarthritis, and Hemin can regulate the expression of mitochondria-related proteins.
Objective: To study the regulatory effect of Hemin on oxidative stress in mouse chondrocytes and its interventional effect and mechanism in knee osteoarthritis.
METHODS: (1) In vitro cell experiment: Primary chondrocytes from C57BL/6 mice were extracted and induced with 10 ng/mL interleukin-1β to construct an in vitro chondrocyte model of osteoarthritis. The optimal concentration of Hemin (0, 1, 10, 20, 40, 80, and 160 μmol/L) for the intervention in mouse chondrocytes was determined by cell counting kit-8 method. Chondrocytes were randomly divided into control group, model group (interleukin-1β) and Hemin group (interleukin-1β+Hemin). Reactive oxygen species, mitochondrial membrane potential and apoptosis of chondrocytes in each group were detected. (2) In vivo experiment: Adult C57BL/6 mice were randomly divided into normal group, model group (osteoarthritis) and Hemin group (osteoarthritis+Hemin), with eight mice in each group. After 4 weeks of Hemin treatment, the behavioral test and histopathological observation of the knee joint were performed in each group. Changes in extracellular matrix-related protein expression and apoptosis in chondrocytes and the expression level of Nrf2/HO-1 protein in cartilage tissue were detected.
RESULTS AND CONCLUSION: In vitro experiment: the optimal concentration of Hemin on primary chondrocytes was 40 μmol/L. Compared with the model group, the level of reactive oxygen species was significantly reduced, the mitochondrial membrane potential was significantly improved, and the apoptosis of chondrocytes was reduced in the hemin-treated interleukin-1β-induced chondrocytes. In vivo experiment: After 4 weeks of treatment, compared with the model group, the lower limb function of mice in the Hemin group was significantly improved, the histopathological score was significantly improved, and the apoptosis of knee chondrocytes was significantly reduced. All these findings indicate that Hemin can alleviate oxidative stress, restore mitochondrial function and reduce apoptosis in mouse chondrocytes induced by interleukin-1β. Hemin can improve extracellular matrix degradation, promote chondrocyte anabolism, reduce catabolism and reduce chondrocyte apoptosis in knee osteoarthritis. It may act by activating the chondrocyte Nrf2/HO-1 signaling pathway in the inflammatory environment.

Key words: knee osteoarthritis, Hemin, oxidative stress, mitochondria, apoptosis, cartilage injury

CLC Number: